Efectos terapéuticos del uso de Cannabis medicinal en personas con Transtorno del Espectro Autista (TEA)
##plugins.themes.bootstrap3.article.main##
Resumen
Objetivo: Analizar la mejoría de los pacientes con Trastorno del Espectro Autista(TEA) con el tratamiento a base de Cannabis. Métodos: Se realizó una revisión integradora en la que se utilizaron las siguientes bases de datos: Biblioteca Virtual em Saúde (BVS), National Library e National Institutes of Health (Pubmed), Cochrane y EBSCO, donde fueron seleccionados al final 22 artículos. Además, los operadores booleanos "Y", "O" fueron usados en investigaciones relacionadas con el TEA y el cannabis. Los criterios de inclusión utilizados fueron: artículos publicados en los últimos 5 años, escritos en portugués, inglés y español, publicados en revistas científicas. Resultados: El tratamiento a base de cannabis exhibió resultados satisfactorios en el tratamiento de pacientes con TEA en los estudios analizados. Hay evidencia de la mejoría en los principales síntomas del trastorno, como: alteraciones del sueño, dificultad en la interacción social, restricciones dietéticas, crisis de conducta y convulsiones. Consideraciones finales: Al analizar los artículos, se pudo ver que el uso de Cannabis como forma de tratamiento en pacientes con TEA el trajo resultados positivos. Sin embargo, se necesitan más estudios por un periodo de tiempo más largo para demostrar que el uso de Cannabis es beneficioso.
##plugins.themes.bootstrap3.article.details##
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Citas
2. AGARWAL R, et al. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. Revista eletrônica BMC Psychiatry, 2019; 19(1): 328.
3. ARAN A, et al. Cannabinoid treatment for autism:a proof-of-concept randomized trial. Revista eletrônica Molecular Autism, 2021; 12: 6.
4. BAR-LEV SCHLEIDER L, et al. Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy. Revista eletrônica Scientific Reports, 2019; 9: 200.
5. BRASIL. Manual do Ministério da Saúde. 2022. Disponível em: https ://www.gov.br/saude/pt-br/assuntos/noticias/2022/abril/tea-saiba-o-que-e-o-transtorno-do-espec tro-autista-e-como-o-sus-tem-dado-assistencia-a-pacientes-e-familiares. Acessado em: 05 jun. 2024.
6. CRISTINO L, et al. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Revista eletrônica Nature Reviews Neurology, 2019; 16: 9–29.
7. CRUMP C, et al. Preterm or Early Term Birth and Risk of Autism. Revista eletrônica American Academy of Pediatrics, 2021.
8. DUVALL SW, et al. Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders. Revista eletrônica American Academy of Pediatrics, 2019; 143(2).
9. FLEURY-TEIXEIRA P, et al. Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use. Revista eletrônica Frontiers in Neurology, 2019; 10: 1145.
10. MAENNER MJ, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. Revista eletrônica MMWR Surveill Summ. 2024; 72(2): 1-14.
11. MALES WITH AUTISM SPECTRUM DISORDER. Journal of Autism and Developmental Disorders; 2022; 52: 4164–4171.
12. MANSELL H, et al. Medical cannabis in school[s: A qualitative study on the experiences of clinicians. Revista eletrônica Paediatrics & Child Health, 2022; 28: 113-118.
13. MANSELL H, et al. Medical cannabis in schools: The experiences of caregivers. Revista eletrônica Paediatrics & Child Health, 2023; 28: 102–106.
14. NETO P, et al. Cannabis: 12.000 anos de experiências e preconceitos. BrJP. São Paulo. 2023; 6(2): 80-4.
15. OMS. Transtorno do espectro autista. Disponível em: https ://www.paho.org/pt/topicos/transtorno-do-espectro-autista. Acesso em: 8 de junho de 2024.
16. PONTON JA, et al. A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report. Revista eletrônica Journal of Medical Case Reports, 2020; 14: 162.
17. QUILLET JC, et al. A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment. Revista eletrônica Scientifc Reports, 2023; 13: 13022.
18. RANG HP, DALE MM, RITTER JM, FLOWER RJ, HENDERSON G. Farmacologia. Rio de Janeiro, 9.
19. RAZ N, et al. Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report. Revista eletrônica Frontiers in Pharmacology, 2022; 13: 979403.
20. SCHNAPP A, et al. A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ. Revista eletrônica Biomedicines, 2022; 13; 10(7): 1685.
21. SIANI-ROSE M, et al. Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder. Revista eletrônica Cannabis and Cannabinoid Research, 2021; 8(1): 126-137.
22. SILVA EAD Junior, et al. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial. Revista eletrônica Trends in Psychiatry and Psychotherapy, 2024; 46: 20210396 – 3.
23. SOLEITI MA, et al. Brief Report: Suspected Cannabis‐Induced Mania and Psychosis in Young Adult
24. STOLAR O, et al. Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety. Revista eletrônica Frontiers in Pharmacology, 2022; 29(13): 977484.
25. ZAMBERLETTI E, et al. The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models. International Journal of Molecular Sciences, 2017; 18(9): 1916.
26. ZOU S e KUMAR U. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Revista eletrônica International Journal of Molecular Sciences, 2018; 19(3): 833.